Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study.
about
The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment.Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes.Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.Temporal changes in the exercise pressor reflex in type 1 diabetic rats.Chronic idiopathic axonal polyneuropathy: a systematic review.Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises.Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes.Methylglyoxal Requires AC1 and TRPA1 to Produce Pain and Spinal Neuron Activation.Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial.A 10-yr follow-up study for the detection of peripheral neuropathy in young patients with type 1 diabetes.The role of serum methylglyoxal on diabetic peripheral and cardiovascular autonomic neuropathy: the ADDITION Denmark study.Methylglyoxal Disrupts Paranodal Axoglial Junctions via Calpain Activation.
P2860
Q33607272-EC081DC1-ABB6-4137-BEDB-6E74FAE61E2FQ34762475-6C81AD9D-AD7A-4DDB-9C19-1697676C5AF0Q35778812-947DF836-EB83-464B-A318-E1CD0ADC3E62Q36684873-E04108FD-DA10-4ECB-835B-281174218C6DQ38639851-21A9353C-48A4-4D60-BBC2-F2233E1FDB78Q38768010-5440F899-D743-4C4E-8B83-5DA4F0092E10Q38956425-C7E2D71B-3384-428D-8D7E-08AEB9BB2932Q39285661-E7F4E2A5-AC35-4DCE-AD7C-53D01BD2BCAEQ40731163-CFC5F5CF-FA94-43E9-836D-45165F503645Q47101216-862075BA-C2DB-4B47-A916-FB08312A112EQ50550209-36BE2440-133F-4189-A30B-EE1DC638FED6Q50555123-779B9D2F-C87F-4D82-8E8E-F35D574CE324Q50565632-028615F5-9496-4A52-A410-F8F19350FFF4Q52691523-A3F58F3C-052B-43E7-A00E-F13566366C54
P2860
Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Small- and large-fiber neuropa ...... ein glycation: the Oslo Study.
@en
Small- and large-fiber neuropa ...... ein glycation: the Oslo Study.
@nl
type
label
Small- and large-fiber neuropa ...... ein glycation: the Oslo Study.
@en
Small- and large-fiber neuropa ...... ein glycation: the Oslo Study.
@nl
prefLabel
Small- and large-fiber neuropa ...... ein glycation: the Oslo Study.
@en
Small- and large-fiber neuropa ...... ein glycation: the Oslo Study.
@nl
P2093
P2860
P356
P1433
P1476
Small- and large-fiber neuropa ...... ein glycation: the Oslo Study.
@en
P2093
Bassam Karimé
Ellen Jørum
Kari Anne Sveen
Knut Dahl-Jørgensen
Kristian F Hanssen
Svein Ivar Mellgren
Vincent M Monnier
P2860
P304
P356
10.2337/DC13-0788
P407
P577
2013-09-11T00:00:00Z